Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | L01BC03 |
UNII: | 1548R74NSZ |
InChI Key | WFWLQNSHRPWKFK-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C8H9FN2O3 |
Molecular Weight | 200.17 |
AlogP | -0.02 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 64.09 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 14.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | DNA inhibitor | EMA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 4 | D009369 | ClinicalTrials |
Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Cholangiocarcinoma | 3 | D018281 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
Rectal Neoplasms | 3 | D012004 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Adenocarcinoma | 3 | D000230 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Urinary Bladder Neoplasms | 3 | D001749 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Rectal Neoplasms | 3 | D012004 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Carcinoma, Pancreatic Ductal | 2 | D021441 | ClinicalTrials |
Carcinoma, Neuroendocrine | 2 | D018278 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Squamous Cell Carcinoma of Head and Neck | 2 | D000077195 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Gallbladder Neoplasms | 2 | D005706 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Nasopharyngeal Neoplasms | 2 | D009303 | ClinicalTrials |
Liver Diseases | 1 | D008107 | ClinicalTrials |
Kidney Diseases | 1 | D007674 | ClinicalTrials |
Uterine Cervical Neoplasms | 1 | D002583 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 17902-23-7 |
ChEBI | 32188 |
ChEMBL | CHEMBL20883 |
DrugBank | DB09256 |
DrugCentral | 4398 |
EPA CompTox | DTXSID8021305 |
FDA SRS | 1548R74NSZ |
Guide to Pharmacology | 10513 |
KEGG | C12673 |
PubChem | 5386 |
SureChEMBL | SCHEMBL4552 |